FDA Approves Unknown Drug — RISING

# FDA Approval Newswire Rising Pharmaceuticals received FDA approval for a new generic drug formulation (ANDA090431) on December 28, 2010, positioning the company to capture market share in an established therapeutic category. The approval expands Rising's generic portfolio and enables the manufacturer to compete directly with branded competitors, potentially exerting downward pricing pressure in the segment.